H. Michael Arrighi

8.6k total citations · 2 hit papers
52 papers, 6.4k citations indexed

About

H. Michael Arrighi is a scholar working on Psychiatry and Mental health, Physiology and Molecular Biology. According to data from OpenAlex, H. Michael Arrighi has authored 52 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Psychiatry and Mental health, 15 papers in Physiology and 8 papers in Molecular Biology. Recurrent topics in H. Michael Arrighi's work include Dementia and Cognitive Impairment Research (22 papers), Alzheimer's disease research and treatments (13 papers) and Chronic Disease Management Strategies (6 papers). H. Michael Arrighi is often cited by papers focused on Dementia and Cognitive Impairment Research (22 papers), Alzheimer's disease research and treatments (13 papers) and Chronic Disease Management Strategies (6 papers). H. Michael Arrighi collaborates with scholars based in United States, United Kingdom and Netherlands. H. Michael Arrighi's co-authors include Ron Brookmeyer, Kathryn Ziegler‐Graham, Elizabeth M. Johnson, Irva Hertz‐Picciotto, Alex Ward, Jesse M. Cedarbaum, Michael N. Cook, Catherine A. Dye, James L. Fozard and Nicole L. Baker and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Epidemiology and The Lancet Neurology.

In The Last Decade

H. Michael Arrighi

50 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Forecasting the global burden of Alzheimer's disease

2007 2.5k citations H. Michael Arrighi et al. Alzheimer s & Dementia profile →
Mild cognitive impairment: Disparity of incidence and prevalence estimates

2012 414 citations Alex Ward, H. Michael Arrighi et al. Alzheimer s & Dementia profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H. Michael Arrighi United States	29	2.1k	1.9k	1.0k	715	576	52	6.4k
Ruth Peters United Kingdom	52	1.9k 0.9×	1.9k 1.0×	1.3k 1.3×	661 0.9×	487 0.8×	193	13.0k
Alina Solomon Finland	45	2.9k 1.4×	2.6k 1.4×	1.2k 1.2×	927 1.3×	557 1.0×	174	7.5k
Wilson Jacob Filho Brazil	48	2.3k 1.1×	1.4k 0.7×	1.1k 1.1×	762 1.1×	279 0.5×	322	8.6k
María M. Corrada United States	43	3.1k 1.5×	2.7k 1.4×	859 0.8×	1.2k 1.7×	702 1.2×	171	7.5k
Deborah Gustafson United States	49	3.2k 1.5×	1.9k 1.0×	1.1k 1.0×	807 1.1×	426 0.7×	235	8.8k
Craig Ritchie United Kingdom	44	2.9k 1.4×	2.4k 1.3×	1.1k 1.1×	899 1.3×	919 1.6×	210	7.7k
Rachel A. Whitmer United States	45	2.8k 1.3×	2.9k 1.5×	694 0.7×	1.1k 1.5×	357 0.6×	223	9.3k
Raj C. Shah United States	44	3.0k 1.4×	3.3k 1.7×	1.1k 1.1×	842 1.2×	442 0.8×	225	8.7k
Jean‐Marc Orgogozo France	36	2.1k 1.0×	2.4k 1.3×	751 0.7×	1.4k 1.9×	778 1.4×	81	6.6k
Ming‐Xin Tang United States	43	4.1k 1.9×	3.0k 1.6×	1.7k 1.7×	1.1k 1.6×	502 0.9×	75	10.0k

Countries citing papers authored by H. Michael Arrighi

Since Specialization

Citations

This map shows the geographic impact of H. Michael Arrighi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Michael Arrighi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Michael Arrighi more than expected).

Fields of papers citing papers by H. Michael Arrighi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Michael Arrighi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Michael Arrighi. The network helps show where H. Michael Arrighi may publish in the future.

Co-authorship network of co-authors of H. Michael Arrighi

This figure shows the co-authorship network connecting the top 25 collaborators of H. Michael Arrighi. A scholar is included among the top collaborators of H. Michael Arrighi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Michael Arrighi. H. Michael Arrighi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Arrighi, H. Michael, Jerome Barakos, Frederik Barkhof, et al.. (2015). Amyloid-related imaging abnormalities-haemosiderin (ARIA-H) in patients with Alzheimer's disease treated with bapineuzumab: a historical, prospective secondary analysis. Journal of Neurology Neurosurgery & Psychiatry. 87(1). jnnp–2014. 49 indexed citations

Hauber, Brett, Ateesha F. Mohamed, F. Reed Johnson, et al.. (2014). Understanding the relative importance of preserving functional abilities in Alzheimer’s disease in the United States and Germany. Quality of Life Research. 23(6). 1813–1821. 28 indexed citations

Ward, Alex, et al.. (2013). Rate of Conversion from Prodromal Alzheimer's Disease to Alzheimer's Dementia: A Systematic Review of the Literature. SHILAP Revista de lepidopterología. 3(1). 320–332. 289 indexed citations

Barkhof, Frederik, Marita Daams, Philip Scheltens, et al.. (2013). An MRI Rating Scale for Amyloid-Related Imaging Abnormalities with Edema or Effusion. American Journal of Neuroradiology. 34(8). 1550–1555. 47 indexed citations

Sperling, Reisa A., Stephen Salloway, David J. Brooks, et al.. (2012). Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis. The Lancet Neurology. 11(3). 241–249. 366 indexed citations

Sanden, Suzy Van, et al.. (2012). PND10 Faster Cognitive Decline is Associated With Decreasing Survival in Patients With Alzheimer'S Disease. Value in Health. 15(7). A547–A547. 1 indexed citations

Ward, Alex, et al.. (2012). Mild cognitive impairment: Disparity of incidence and prevalence estimates. Alzheimer s & Dementia. 8(1). 14–21. 414 indexed citations breakdown →

Ward, Alex, Sheila Crean, Catherine J. Mercaldi, et al.. (2011). Prevalence of Apolipoprotein E4 Genotype and Homozygotes (APOE e4/4) among Patients Diagnosed with Alzheimer’s Disease: A Systematic Review and Meta-Analysis. Neuroepidemiology. 38(1). 1–17. 240 indexed citations

Arrighi, H. Michael, Trent McLaughlin, & Christopher Leibman. (2010). Prevalence and Impact of Dementia-related Functional Limitations in the United States, 2001 to 2005. Alzheimer Disease & Associated Disorders. 24(1). 72–78. 14 indexed citations

10.

Baker, Nicole L., H. Michael Arrighi, Michael N. Cook, et al.. (2010). P3‐065: Alzheimer's disease is associated with increased incidence of seizures among patients in the United Kingdom, 1988‐2009. Alzheimer s & Dementia. 6(4S_Part_15). 1 indexed citations

11.

Malone, Daniel C., Trent P. McLaughlin, Peter Wahl, et al.. (2009). Burden of Alzheimer's disease and association with negative health outcomes.. PubMed. 15(8). 481–8. 42 indexed citations

12.

Arrighi, H. Michael, et al.. (2009). Adverse Events Associated With Common Therapy Regimens for Moderate-to-Severe Crohn's Disease. The American Journal of Gastroenterology. 104(10). 2524–2533. 161 indexed citations

13.

Khosla, Sundeep, H. Michael Arrighi, L. Joseph Melton, et al.. (2002). Correlates of Osteoprotegerin Levels in Women and Men. Osteoporosis International. 13(5). 394–399. 172 indexed citations

14.

Hertz‐Picciotto, Irva, H. Michael Arrighi, & Suh‐Woan Hu. (2000). Does Arsenic Exposure Increase the Risk for Circulatory Disease?. American Journal of Epidemiology. 151(2). 174–181. 41 indexed citations

15.

Maier, William C., et al.. (1997). Indoor risk factors for asthma and wheezing among Seattle school children.. Environmental Health Perspectives. 105(2). 208–214. 95 indexed citations

16.

Arrighi, H. Michael, et al.. (1995). Childhood Asthma and Adult Height: Data from NHANES II. Pediatric Asthma Allergy & Immunology. 9(3). 157–163. 2 indexed citations

17.

Arrighi, H. Michael & Irva Hertz‐Picciotto. (1995). Controlling for Time-since-Hire in Occupational Studies Using Internal Comparisons and Cumulative Exposure. Epidemiology. 6(4). 415–418. 15 indexed citations

18.

Arrighi, H. Michael & Irva Hertz‐Picciotto. (1994). The Evolving Concept of the Healthy Worker Survivor Effect. Epidemiology. 5(2). 189–196. 410 indexed citations

19.

Arrighi, H. Michael, Harry A. Guess, E. Jeffrey Metter, & James L. Fozard. (1990). Symptoms and signs of prostatism as risk factors for prostatectomy. The Prostate. 16(3). 253–261. 87 indexed citations

20.

Friede, Andrew, et al.. (1986). Do the sisters of childbearing teenagers have increased rates of childbearing?. American Journal of Public Health. 76(10). 1221–1224. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact